Impressive early phase II clinical data reported for OvaRex in relapsed ovarian cancer Dec. 29, 1999 No Comments
SuperGen acquires equity interest in AVI BioPharma and negotiating rights to Avicine Dec. 28, 1999 No Comments
CeaVac trial reaches accrual goal; phase II trial will be expanded to phase III Dec. 23, 1999 No Comments
RSS